Literature DB >> 3933781

[Biotransformation of amiodaquine and prophylaxis of Plasmodium falciparum malaria].

E Pussard, F Verdier, M C Blayo, J J Pocidalo.   

Abstract

The authors have devised a specific HPLC method for amodiaquine assay which demonstrated that the drug disappeared rapidly from the blood of subjects under prophylaxis for malaria (10 mg/kg/week in a single oral dose). The main metabolite was identified as the monodesethyl derivative which is the only active form of the drug. The low erythrocytic levels of the metabolite, observed at day +7, might account for the failure in the prophylaxis of P. falciparum malaria with amodiaquine in a few cases. The in vitro activity of monodesethyl amodiaquine should be evaluated during the chemosensitivity tests and the chemoprophylaxis schedule, re-evaluated.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3933781

Source DB:  PubMed          Journal:  C R Acad Sci III        ISSN: 0764-4469


  6 in total

1.  Pharmacokinetics of intramuscular amopyroquin in healthy subjects and determination of a therapeutic regimen for Plasmodium falciparum malaria.

Authors:  F Verdier; E Pussard; F Clavier; J Le Bras; C Gaudebout
Journal:  Antimicrob Agents Chemother       Date:  1989-03       Impact factor: 5.191

2.  Effect of monodesethyl amodiaquine on human polymorphonuclear neutrophil functions in vitro.

Authors:  M T Labro; J el Benna
Journal:  Antimicrob Agents Chemother       Date:  1991-05       Impact factor: 5.191

3.  Disposition of amopyroquin in rats and rabbits and in vitro activity against Plasmodium falciparum.

Authors:  E Pussard; F Verdier; F Faurisson; F Clavier; F Simon; C Gaudebout
Journal:  Antimicrob Agents Chemother       Date:  1988-04       Impact factor: 5.191

4.  Disposition of monodesethylamodiaquine after a single oral dose of amodiaquine and three regimens for prophylaxis against Plasmodium falciparum malaria.

Authors:  E Pussard; F Verdier; F Faurisson; J M Scherrmann; J Le Bras; M C Blayo
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

5.  The disposition of amodiaquine in man after oral administration.

Authors:  P Winstanley; G Edwards; M Orme; A Breckenridge
Journal:  Br J Clin Pharmacol       Date:  1987-01       Impact factor: 4.335

6.  Pharmacokinetics of intravenous amodiaquine.

Authors:  N J White; S Looareesuwan; G Edwards; R E Phillips; J Karbwang; D D Nicholl; C Bunch; D A Warrell
Journal:  Br J Clin Pharmacol       Date:  1987-02       Impact factor: 4.335

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.